Earlier studies examining changes in tumour biology during the menstrual cycle have focused mainly on ER and PgR protein levels and produced inconsistent results [20–27] reflecting the difficulties of reliably assigning the timing of the menstrual cycle. The gene discussed is ESR1; the disease is neoplasm.